Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma

Nissen, L.H.C.; Pierik, M.; Derikx, L.A.A.P.; Jong, E. de; Kievit, W.; Heuvel, T.R.A. van den; ... ; IBD & Melanoma Grp (2017)

Article / Letter to editor

• inflammatory bowel diseases
• melanoma
• immunosuppressive therapy

• All authors: Nissen, L.H.C.; Pierik, M.; Derikx, L.A.A.P.; Jong, E. de; Kievit, W.; Heuvel, T.R.A. van den; Rosendael, A.R. van; Plasmeijer, E.I.; Dewint, P.; Verhoeven, R.H.A.; Overbeek, L.I.H.; Nagtegaal, I.D.; Hoentjen, F.; Meulen-de Jong, A.E. van der; Dutch Initiative Crohn & Colitis; PALGA Grp; IBD & Melanoma Grp
• Date: 2017-11-30
• Journal: Inflammatory Bowel Diseases
• Volume: 23
• Issue: 11
• Pages: 2018 - 2026
• DOI: doi:10.1097/MIB.0000000000001191